Laboratory plasma and BALF examinations of patients with NSCLC-CIP showed an increasing spectrum of common inflammatory cytokines, such as interleukin (IL)-1β, IL-6, IL-17A, IL-35, C-reactive protein, and procalcitonin (72, 76, 80, 81). Here, IL6 is linked to non-small cell lung carcinoma.